Pupillographie Als Screeningtest für Cerebrale Insulinresistenz
The study conducted by the University Hospital Tuebingen aims to explore the potential of pupillography as a noninvasive screening tool for cerebral insulin resistance, which is relevant in the context of obesity and metabolic disorders. Given the increasing prevalence of obesity and associated metabolic diseases, this research could pave the way for novel diagnostic approaches in managing these conditions. The findings may attract interest from pharmaceutical companies focusing on metabolic disorders, particularly those developing insulin-related therapies. However, the absence of FDA regulation for the drug and device used in this study may limit immediate commercial applications. Further validation and potential partnerships will be essential for translating these findings into clinical practice.
Indication: Obesity
Modality: small molecule
Target: Cerebral insulin action and autonomic nervous system activity as assessed by pupillography.
Sponsor: University Hospital Tuebingen
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 16, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Cerebral insulin action and autonomic nervous system activity as assessed by pupillography.
View original source fields
Condition raw: Obesity
Condition normalized: Obesity
Modality raw: small molecule
Modality normalized: small molecule
Target raw: Cerebral insulin action and autonomic nervous system activity as assessed by pupillography.
Target normalized: Cerebral insulin action and autonomic nervous system activity as assessed by pupillography.